Fox Carey J

Avg. Two Year Performance

No purchase track record

3% Avg. Sale Return

1% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(5%)	(9%)	1%	2%	3%
Sale Success Rate	7 of 18	6 of 18	7 of 18	9 of 18	9 of 18

Santarus Inc.

Drugs » Drug Manufacturers - Other

Sr VP, General Counsel:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--